Featured Research

from universities, journals, and other organizations

First large scale study links autism and autoimmunity

Date:
August 29, 2013
Source:
American Autoimmune Related Diseases Association (AARDA)
Summary:
A new study of more than 2,700 mothers of children with autism shows that about one in 10 mothers have antibodies in their bloodstream that react with proteins in the brain of their babies.

A new, large-scale study of more than 2,700 mothers of children with autism shows that about one in 10 mothers have antibodies in their bloodstream that react with proteins in the brain of their babies.

The research, published in Molecular Psychology (August 20, 2013) indicates that while the blood-brain barrier in the adult women prevents them from being harmed by the antibodies, that same filter in the fetuses is not well-developed enough and so may allow the "anti-brain" antibodies to pass through to the babies' brains, possibly causing autism.

The study was led by Dr. Betty Diamond, head of the Center for Autoimmune and Musculoskeletal Disorders at The Feinstein Institute for Medical Research in Long Island, New York, who said the very large sample size "gives a clearer impression of the prevalence of these antibodies."

"We at AARDA applaud Dr. Diamond's research into an area that concerns all parents," said Virginia T. Ladd, President of American Autoimmune Related Diseases Association, Inc. (AARDA).

According to AARDA, in healthy people, when a foreign invader, such as a virus or bacteria, enters the body, the immune system produces antibodies to attack those foreign substances. In people with autoimmunity, the immune system mistakenly recognizes the body's own healthy tissues and organs as foreign invaders and produces antibodies to attack them. These auto-antibodies -- or antibodies produced against the self -- then cause disease. The disease that results depends upon which tissues and/or organs the antibodies are attacking.

Some 50 million Americans live and cope with autoimmune disease (AD), 75 percent of whom are women. AD is one of the top 10 leading causes of death of women under the age of 65. It encompasses more than 100 diseases, including psoriasis, Graves' disease, Sjogren's syndrome, multiple sclerosis, rheumatoid arthritis, Crohn's disease and lupus. It is responsible for more than $100 billion in direct health care costs annually.


Story Source:

The above story is based on materials provided by American Autoimmune Related Diseases Association (AARDA). Note: Materials may be edited for content and length.


Journal Reference:

  1. L Brimberg, A Sadiq, P K Gregersen, B Diamond. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Molecular Psychiatry, 2013; DOI: 10.1038/mp.2013.101

Cite This Page:

American Autoimmune Related Diseases Association (AARDA). "First large scale study links autism and autoimmunity." ScienceDaily. ScienceDaily, 29 August 2013. <www.sciencedaily.com/releases/2013/08/130829092648.htm>.
American Autoimmune Related Diseases Association (AARDA). (2013, August 29). First large scale study links autism and autoimmunity. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/08/130829092648.htm
American Autoimmune Related Diseases Association (AARDA). "First large scale study links autism and autoimmunity." ScienceDaily. www.sciencedaily.com/releases/2013/08/130829092648.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins